Bank Julius Baer & Co. Ltd, Zurich Axsome Therapeutics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$23.7 - $41.39 $10,665 - $18,625	-450 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$30.7 - $43.36 $214,193 - $302,522	-6,977 Reduced 93.94%	450 $17,000
Q1 2020 May 13, 2020	BUY	$41.2 - $101.31 $305,992 - $752,429	7,427 New	7,427 $436,000

327

38M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.56B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.